Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/19/2012 | CA2812917A1 Production of plants having improved water-deficit tolerance |
04/19/2012 | CA2812791A1 Chimeric spider silk and uses thereof |
04/19/2012 | CA2812643A1 Method for purification of complement factor h |
04/19/2012 | CA2811787A1 Variant cbh i polypeptides |
04/18/2012 | EP2441846A2 Immunostimulatory combinations of TNFRSF, TLR, NLR, RHR, purinergic receptor, and cytokine receptor agoinsts for vaccines and tumor immunotherapy |
04/18/2012 | EP2441834A1 Differentially Fluorescent Yeast Biosensors for the Detection and Biodegration of Chemical Agents |
04/18/2012 | EP2441776A1 Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain |
04/18/2012 | EP2441775A1 Protein |
04/18/2012 | EP2441774A1 Peptides having zinc finger domains and uses thereof |
04/18/2012 | EP2441773A1 Plants having enhanced yield-related traits and a method for making the same |
04/18/2012 | EP2441772A1 Antifreeze substance |
04/18/2012 | EP2441771A1 New 12alpha-hydroxysteroid dehydrogenase mutants, method for their manufacture and application thereof |
04/18/2012 | EP2441754A1 A new dimedon derivative and a method for the purification of PNA and peptide oligomers |
04/18/2012 | EP2441474A1 Methods and compositions for modulating adipocyte function |
04/18/2012 | EP2441471A1 Reassortant influenza viruses |
04/18/2012 | EP2441470A1 Methods for producing an immune response to tuberculosis |
04/18/2012 | EP2441469A1 Methods for producing an immune response to tuberculosis |
04/18/2012 | EP2441468A2 Immunotherapy by using cell capable of co-expressing target antigen and cd1d and pulsed with cd1d ligand |
04/18/2012 | EP2441465A1 Compositions and methods for healthy pregnancy |
04/18/2012 | EP2440581A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
04/18/2012 | EP2440577A1 Truncated actriib-fc fusion proteins |
04/18/2012 | EP2440576A1 Methods for increasing thermogenic adipocytes |
04/18/2012 | EP2440575A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy |
04/18/2012 | EP2440574A1 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof |
04/18/2012 | EP2440573A1 Bacillus strain for increased protein production |
04/18/2012 | EP2440570A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
04/18/2012 | EP2440248A1 Hydrophobins for dispersing active agents |
04/18/2012 | EP2440241A1 Growth hormone polypeptides and methods of making and using same |
04/18/2012 | EP2440238A1 Methods of treatment |
04/18/2012 | EP2440234A2 Immunological targeting of pathological tau proteins |
04/18/2012 | EP2440228A1 Glucose-regulating polypeptides and methods of making and using same |
04/18/2012 | EP2440227A2 Melanocortin receptor-specific peptides |
04/18/2012 | EP2440226A1 Vaccine therapy for choroidal neovascularization |
04/18/2012 | EP2231701B1 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
04/18/2012 | EP2209899B1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
04/18/2012 | EP2112998B1 Rgd containing recombinant gelatin |
04/18/2012 | EP2083855B1 Measles virus nucleoprotein for treating atherosclerosis |
04/18/2012 | EP2064233B1 Method of increasing resistance against soybean rust in transgenic plants |
04/18/2012 | EP1943273B1 Novel activin receptor and uses thereof |
04/18/2012 | EP1682577B1 Cell-based assays employing voltage and calcium dyes |
04/18/2012 | EP1676860B1 Process for producing antithrombin III composition |
04/18/2012 | EP1534750B1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
04/18/2012 | EP1183368B1 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
04/18/2012 | EP1054985B1 Hybrid seed production |
04/18/2012 | EP1005488B9 Receptor that binds trail |
04/18/2012 | EP0894143B2 Vmp-like sequences of pathogenic borrelia |
04/18/2012 | EP0618925B2 Antisense oligonucleotides |
04/18/2012 | CN1958601B 八棱丝瓜蛋白1的快速分离纯化及其晶体生长技术 Luffaculin Rapid Purification and crystal growth technology 1 |
04/18/2012 | CN102422161A 利用糖蛋白的糖基化的癌症诊断方法 Glycosylation method of cancer diagnosis using the glycoprotein |
04/18/2012 | CN102421905A 杀虫蛋白和使用它们的方法 Insecticidal proteins and methods of using them |
04/18/2012 | CN102421892A 二鸟苷酸环化酶、其生产方法及其在制备环化-di-GMP及其类似物中的应用 Two guanylate cyclase, its production method and in the preparation of the cyclization -di-GMP and its analogs Application |
04/18/2012 | CN102421795A 针对肌钙蛋白i的抗体及其使用方法 Antibodies against troponin i and method of use |
04/18/2012 | CN102421794A 用于纯化靶物多肽的方法 A method for purification of a target polypeptide in |
04/18/2012 | CN102421793A 具有延迟开花期或抑制生长功能的多肽,编码所述多肽的多核苷酸及其用途 Having a delayed flowering or inhibiting the growth-functional polypeptide, a polynucleotide encoding the polypeptide and use thereof |
04/18/2012 | CN102421792A Axmi-001, axmi-002, axmi-030, axmi-035, and axmi-045: toxin genes and methods for their use |
04/18/2012 | CN102421791A 稳定化逆转录酶融合蛋白 Stabilizing the reverse transcriptase fusion protein |
04/18/2012 | CN102421789A Target-specific non-antibody protein and method for preparing the same |
04/18/2012 | CN102421739A 羧酸化合物 Carboxylic acid compound |
04/18/2012 | CN102421449A 含14型肺炎球菌糖的组合 Portfolio containing 14 pneumococcal saccharide |
04/18/2012 | CN102421447A 用peg标记干扰素的方法 Labeled with a peg interferon method |
04/18/2012 | CN102417539A 抗菌蛋白及编码基因、表达体系、复性系统和应用 Antibacterial proteins and coding genes, expression systems, complex systems and applications |
04/18/2012 | CN102417538A Bt protein Cry68Aa1 and encoding gene and application thereof |
04/18/2012 | CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
04/18/2012 | CN102416173A 预防与猪环状病毒-2相关的心肌炎、流产和宫内感染 Prevention and porcine circovirus -2 associated myocarditis, abortion and intrauterine infection |
04/18/2012 | CN102416163A 一种含有植物血球凝集素或植物血球凝集素亚型的组合物 Containing phytohemagglutinin or phytohemagglutinin subtype composition |
04/18/2012 | CN101899104B 一种鲨鱼软骨血管生成抑制因子小分子多肽及其生产纯化方法和应用 One kind of shark cartilage angiogenesis inhibitor purified small peptides and their production methods and applications |
04/18/2012 | CN101870977B 培育抗黄萎病转基因棉花的方法及其专用表达载体 Verticillium wilt resistance transgenic cotton cultivation methods and its special expression vector |
04/18/2012 | CN101851604B 一种人血白蛋白的生产方法 A human serum albumin production methods |
04/18/2012 | CN101851283B 小金海棠MxCS蛋白及编码基因与应用 Xiaojinensis MxCS protein and coding gene and application |
04/18/2012 | CN101824081B 水稻钾、铵双功能转运分子及应用 Rice potassium, ammonium bi-functional transporter molecules and application |
04/18/2012 | CN101775070B 植物耐逆性相关蛋白及其编码基因和应用 Plant stress tolerance-related protein and its encoding gene and application |
04/18/2012 | CN101757618B 一种嗜群血蜱的重组亚单位疫苗及其制备方法 One kind Haemaphysalis recombinant subunit vaccine and its preparation method |
04/18/2012 | CN101736067B 一种乳清蛋白降血压肽及其制备方法与应用 One kind of whey protein antihypertensive peptides and preparation method and application |
04/18/2012 | CN101724031B 一种与水稻穗型相关蛋白及其编码基因与应用 One kind of rice panicle type associated protein coding gene and application |
04/18/2012 | CN101709082B 一种齐考诺肽制备的方法 A test method Qi Connaught peptides prepared |
04/18/2012 | CN101643503B Neutrophil-activating peptide 2 (72) taken as primary liver cancer markers and application thereof |
04/18/2012 | CN101624422B 日本血吸虫重组多表位抗原及其表达、纯化方法与应用 Schistosoma japonicum and its multi-epitope recombinant expression, purification methods and applications |
04/18/2012 | CN101602802B 一种胸腺肽α1脱盐的工艺 One kind of thymosin α1 desalination process |
04/18/2012 | CN101525381B 一种重组复合干扰素及其表达载体的构建和表达 A composite construction and expression of recombinant interferon and expression vectors |
04/18/2012 | CN101487016B 禽流感疫苗及其制备方法 Bird flu vaccine and its preparation method |
04/18/2012 | CN101173279B Scirr69基因、调节bdnf转录及在生物医学研究、生物治疗药物研发中的应用 Scirr69 genes regulating bdnf transcription and in biomedical research, drug discovery and development in the application of biological treatment |
04/18/2012 | CN101104641B 作为猪生殖和呼吸道征候群疫苗的prrs病毒的融合蛋白 As porcine reproductive and respiratory syndrome virus vaccine prrs fusion proteins |
04/18/2012 | CN101044159B 用肠杆菌科的细菌产生l-氨基酸的方法 Method for generating an amino acid l- bacterial family Enterobacteriaceae |
04/18/2012 | CN101023096B 调节植物叶片寿命的蛋白质,其基因和它们的用途 Lived proteins regulate plant leaves, their genes and their uses |
04/17/2012 | US8158858 Soybean promoters and flower-preferred expression thereof in transgenic plants |
04/17/2012 | US8158857 Monocot seed product comprising a human serum albumin protein |
04/17/2012 | US8158855 Immunization of fish with plant-expressed recombinant proteins |
04/17/2012 | US8158769 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
04/17/2012 | US8158767 Polypeptides and methods for making the same |
04/17/2012 | US8158754 Multiple modified derivatives of gelatin and crosslinked material thereof |
04/17/2012 | US8158753 Anticalins |
04/17/2012 | US8158752 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
04/17/2012 | US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
04/17/2012 | US8158749 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src |
04/17/2012 | US8158603 Fragments of secreted frizzled related protein |
04/17/2012 | US8158602 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
04/17/2012 | US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy |
04/17/2012 | US8158578 Methods for treating neurological deficits |
04/17/2012 | US8158577 Modulation of cartilage homeostasis by active domains of cell binding extracellular matrix molecules |
04/17/2012 | US8158576 composition for treatment of a pathologic disorder having as an active ingredient a therapeutically-effective amount of at least one SV40 VP1 65 amino acid truncated mutant deleted in its carboxy terminal arm, designated VP1 Delta C; treatment of immune-related or neurodegenerative disorders |